• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 34 of 37
CNBC Events
FinanceWhy the Pfizer-Allergan Deal Was a Bad Idea From the Start
By Alan MurrayApril 6, 2016
Pfizer In Merger Talks With Allergan PLC
HealthPfizer and Allergan Scrap $160 Billion Deal
By ReutersApril 6, 2016
Pfizer In Merger Talks With Allergan PLC
FinancePfizer, Allergan to Mutually Terminate Merger
By ReutersApril 5, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
FinanceWall Street Is Betting the Pfizer-Allergan Deal Won’t Happen
By Jen WiecznerApril 5, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
LeadershipHere’s Why Allergan Shares Are Tanking
By ReutersApril 5, 2016
BRITAIN-BUSINESS-TAX-GOOGLE-US
FinanceApril Fools: Beware of Jokes
By Alan MurrayApril 1, 2016
Doctors Without Borders Protests High Cost Of Vaccines
FinancePfizer Just Got Pranked Big Time Before April Fool’s Day Even Started
By Jen WiecznerMarch 31, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthWatchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By ReutersMarch 31, 2016
Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed
HealthWhy Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed
By Sy MukherjeeMarch 16, 2016
Donald Trump
LeadershipHere Are the Companies Donald Trump Would Go After as President
By Ben GeierMarch 16, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
FinanceHere’s How Much More Pfizer Could Save in Taxes With Allergan Deal
By Jen WiecznerFebruary 26, 2016
Pfizer In Merger Talks With Allergan PLC
HealthGenerics and a Strong Dollar Are Cutting Into Pfizer’s Profits
By ReutersFebruary 2, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceBiotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Traders Work On The Floor NYSE As Stock Rout Deepens
FinanceApple Is One of Only 5 Dow Stocks Up Today
By Jen WiecznerJanuary 20, 2016
Leaving Corporate America for a Startup: The Best Decision I Ever Made
Startups & VentureLeaving Corporate America for a Startup: The Best Decision I Ever Made
By Sara PearyJanuary 13, 2016
1...
  • 32
  • 33
  • 34
  • 35
  • 36
37
Most Popular
Economy
The U.S. had a national debt ‘home run’ in its grasp, says Jamie Dimon. But the government did nothing, and now its best option is crisis managementplaceholder alt text
By Fortune EditorsApril 8, 2026
Success
MacKenzie Scott's latest donation takes her HBCU giving to well over $1 billionplaceholder alt text
By Fortune EditorsApril 7, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.